Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
在 CARTITUDE-1 研究中，接受 Ciltacabtagene Autoleucel 治疗的复发/难治性多发性骨髓瘤患者获得长期（≥5 年）缓解和生存。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00760
Jagannath, Sundar; Martin, Thomas G; Lin, Yi; Cohen, Adam D; Raje, Noopur; Htut, Myo; Deol, Abhinav; Agha, Mounzer; Berdeja, Jesus G; Lesokhin, Alexander M; Liegel, Jessica J; Rossi, Adriana; Lieberman-Cribbin, Alex; Usmani, Saad Z; Dhakal, Binod; Parekh, Samir; Li, Hui; Wang, Feng; Montes de Oca, Rocio; Plaks, Vicki; Sun, Huabin; Banerjee, Arnob; Schecter, Jordan M; Lendvai, Nikoletta; Madduri, Deepu; Lengil, Tamar; Zhu, Jieqing; Koneru, Mythili; Akram, Muhammad; Patel, Nitin; Costa Filho, Octavio; Jakubowiak, Andrzej J; Voorhees, Peter M
